APA citiranje

Schramme, F., Crosignani, S., Frederix, K., Hoffmann, D., Pilotte, L., Stroobant, V., . . . Van Den Eynde, B. (2019). Inhibition of tryptophan-dioxygenase activity increases the antitumor efficacy of immune checkpoint inhibitors. American Association for Cancer Research.

Chicago Style (17th ed.) Citation

Schramme, F., S. Crosignani, K. Frederix, D. Hoffmann, L. Pilotte, V. Stroobant, J. Preillon, G. Driessens, and B. Van Den Eynde. Inhibition of Tryptophan-dioxygenase Activity Increases the Antitumor Efficacy of Immune Checkpoint Inhibitors. American Association for Cancer Research, 2019.

MLA citiranje

Schramme, F., et al. Inhibition of Tryptophan-dioxygenase Activity Increases the Antitumor Efficacy of Immune Checkpoint Inhibitors. American Association for Cancer Research, 2019.